TH Open
(Jan 2024)
Treatment Patterns of Cancer-associated Thrombosis in the Netherlands: The Four Cities Study
Fleur H.J. Kaptein,
Noori A.M. Guman,
Susan B. Lohle,
Frederikus A. Klok,
Albert T.A. Mairuhu,
Pieter W. Kamphuisen,
Nick Van Es,
Menno V. Huisman
Affiliations
Fleur H.J. Kaptein
Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands
Noori A.M. Guman
ORCiD Department of Vascular Medicine, Amsterdam University Medical Center Location University of Amsterdam, Amsterdam, the Netherlands
Susan B. Lohle
Department of Vascular Medicine, Amsterdam University Medical Center Location University of Amsterdam, Amsterdam, the Netherlands
Frederikus A. Klok
ORCiD Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands
Albert T.A. Mairuhu
Department of Internal Medicine, Haga Hospital, The Hague, the Netherlands
Pieter W. Kamphuisen
Department of Vascular Medicine, Amsterdam University Medical Center Location University of Amsterdam, Amsterdam, the Netherlands
Nick Van Es
Department of Vascular Medicine, Amsterdam University Medical Center Location University of Amsterdam, Amsterdam, the Netherlands
Menno V. Huisman
Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands
DOI
https://doi.org/10.1055/a-2214-8101
Journal volume & issue
Vol. 08,
no. 01
Abstract
Read online
Background Current guidelines recommend either low-molecular weight heparin (LMWH) or direct oral anticoagulants (DOACs) as first-line treatment in cancer-associated venous thromboembolism (VTE).
Keywords
Published in TH Open
ISSN
2512-9465 (Online)
Publisher
Georg Thieme Verlag KG
Country of publisher
Germany
LCC subjects
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
Website
https://doi.org/10.1055/s-00033990
About the journal
WeChat QR code
Close
